Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Other financing activities (2020)

Historic Other financing activities for Oncology Institute (TOI) over the last 1 years, with Q4 2020 value amounting to -$3.8 million.

  • Oncology Institute's Other financing activities changed N/A to -$3.8 million in Q4 2020 from the same period last year, while for Dec 2023 it was -$3.8 million, marking a year-over-year decrease of 93.72%. This contributed to the annual value of $3.7 million for FY2022, which is N/A changed from last year.
  • Oncology Institute's Other financing activities amounted to -$3.8 million in Q4 2020.
  • Over the past 5 years, Oncology Institute's Other financing activities peaked at $4.1 million during Q1 2020, and registered a low of -$3.8 million during Q4 2020.